NewslettersCancer Stem Cell Newsm6a/IGF2BP3-Driven Serine Biosynthesis Fuels AML Stemness and Metabolic VulnerabilityBy Jamie Kang - May 7, 202501541Researchers identified RNA N6-methyladenosine (m6A) modification as a key regulator of serine biosynthesis in acute myeloid leukemia.[Nature Communications]Full Article